摘要Objective:To investigate the effect of perimenopausal hormone replacement therapy(HRT) on cytokine patterns in a perimenopausal mouse model established by ovarian castration. Methods:The mice were divided into natural menopause group, ovariectomy group and HRT group, with 15 mice in each group, and the estrous cycle, estrous frequency and menopausal time of the mice were determined by vaginal cytology, and the estrous cycle, estrous frequency and menopausal time were compared among the three groups. The serum levels of estradiol (E2) and progesterone (P4) in each group were detected by double-antibody sandwich ELISA, and the levels of interferon gamma (IFN-γ), interleukin-2 (IL-2), IL-4 and IL-10 in the spleen γ tissues of mice were detected by ELISA. Results:The time of menopause (53.07±3.99) d in the HRT group was between that of the natural menopause group (80.80±3.26) d and that of the ovariectomy group (16.27±4.35) d, with a statistically significant difference in the two-by-two comparison of the three groups (P<0.05). The levels of serum E2 (694.4±128.3) ng/L and P4 (14.2±6.0) ng/L in the HRT therapy group are between those of the ovariectomy group and the natural menopause group, with statistically significant differences between the groups (P<0.05). The levels of IL-2(30.9±5.3) pg/ml, IL-4(9.4±1.6) pg/ml, IL-10 (19.7±3.1) pg/ml, IFN-γ(22.0±3.7) pg/ml in the HRT group were all between those of natural menopause group and ovariectomy group. The Th1/Th2 ratio in the ovariectomy group was 7.55±1.57, higher than that in the natural menopause group(1.53±0.48) and HRT group (2.38±0.44), with statistically significant differences(P<0.05). Conclusion:Menopausal HRT can partially correct the imbalance of Th1/Th2 cytokines, which is able to provide an experimental basis for the regulation of menopause-related immune imbalance by HRT.
Abstract：Objective:To investigate the effect of perimenopausal hormone replacement therapy(HRT) on cytokine patterns in a perimenopausal mouse model established by ovarian castration. Methods:The mice were divided into natural menopause group, ovariectomy group and HRT group, with 15 mice in each group, and the estrous cycle, estrous frequency and menopausal time of the mice were determined by vaginal cytology, and the estrous cycle, estrous frequency and menopausal time were compared among the three groups. The serum levels of estradiol (E2) and progesterone (P4) in each group were detected by double-antibody sandwich ELISA, and the levels of interferon gamma (IFN-γ), interleukin-2 (IL-2), IL-4 and IL-10 in the spleen γ tissues of mice were detected by ELISA. Results:The time of menopause (53.07±3.99) d in the HRT group was between that of the natural menopause group (80.80±3.26) d and that of the ovariectomy group (16.27±4.35) d, with a statistically significant difference in the two-by-two comparison of the three groups (P<0.05). The levels of serum E2 (694.4±128.3) ng/L and P4 (14.2±6.0) ng/L in the HRT therapy group are between those of the ovariectomy group and the natural menopause group, with statistically significant differences between the groups (P<0.05). The levels of IL-2(30.9±5.3) pg/ml, IL-4(9.4±1.6) pg/ml, IL-10 (19.7±3.1) pg/ml, IFN-γ(22.0±3.7) pg/ml in the HRT group were all between those of natural menopause group and ovariectomy group. The Th1/Th2 ratio in the ovariectomy group was 7.55±1.57, higher than that in the natural menopause group(1.53±0.48) and HRT group (2.38±0.44), with statistically significant differences(P<0.05). Conclusion:Menopausal HRT can partially correct the imbalance of Th1/Th2 cytokines, which is able to provide an experimental basis for the regulation of menopause-related immune imbalance by HRT.
通讯作者:
WANG Jin-yong. E-mail: hbb1310307450@163.com
引用本文:
HE Bin-bin, ZHANG Ju-shun, WANG Jin-yong. Effect of Menopausal Hormone Replacement Therapy on Cytokine Patterns in a Perimenopausal Mouse Model Established by the Ovarian Castration Method[J]. 中国生物医学工程学报(英文版）, 2024, 33(1): 40-48.
HE Bin-bin, ZHANG Ju-shun, WANG Jin-yong. Effect of Menopausal Hormone Replacement Therapy on Cytokine Patterns in a Perimenopausal Mouse Model Established by the Ovarian Castration Method. Chinese Journal of Biomedical Engineering, 2024, 33(1): 40-48.
[1] Loizzi V, Dellino M, Cerbone M, et al.Hormone replacement therapy in BRCA mutation carriers: how shall we do no harm[J]. Hormones (Athens), 2023,22(1):19-23. [2] Virtanen I, Polo-Kantola P, Kalleinen N.Overnight heart rate variability during sleep disturbance in peri- and postmenopausal women[J]. Behav Sleep Med, 2023:1-11. [3] Lipasti M, Jalava-Broman J, Sillanmki L, et al.Increasing climacteric symptoms in untreated perimenopausal Finnish women: a 10-year cohort study[J]. Climacteric, 2023,26(5):472-478. [4] Ramirez J, Bitterman P, Basu S, et al.Changes in IL-16 expression in the ovary during aging and its potential consequences to ovarian pathology[J]. J Immunol Res, 2022,2022:2870389. [5] Zhu J, Zhang L, Ji M, et al.Elevated adipose differentiation-related protein level in ovariectomized mice correlates with tissue-specific regulation of estrogen[J]. J Obstet Gynaecol Res, 2023,49(4):1173-1179. [6] Park D, Yoon JE, Choi B, et al.Complex extract of polygonatum sibiricum and nelumbinis semen improves menopause symptoms via regulation of estrogen receptor beta in an ovariectomized rat model[J]. Nutrients, 2023,15(11):2443. [7] Ma Xian, Fu Ping, Ling Boyue, et al.Comparative study on the establishment of perimenopausal mouse model by natural aging method and ovarian denudation method[J]. Chinese Journal of Traditional Chinese Medicine,2017,35(3):551-554. [8] Delgobo M, Agnes JP, Gonalves RM, et al.N-acetylcysteine and alpha-lipoic acid improve antioxidant defenses and decrease oxidative stress, inflammation and serum lipid levels in ovariectomized rats via estrogen-independent mechanisms[J]. J Nutr Biochem, 2019,67:190-200. [9] Rochman Y, Kotliar M, Ben-Baruch Morgenstern N, et al. TSLP shapes the pathogenic responses of memory CD4(+) T cells in eosinophilic esophagitis[J]. Sci Signal, 2023,16(802):eadg6360. [10] Altinoz MA, Ozpinar A, Elmaci I.Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma[J]. Neurosurg Rev, 2019,42(2):351-369. [11] Davey DA.Menopausal hormone therapy: a better and safer future[J]. Climacteric, 2018,21(5):454-461. [12] Ozyurek ES, Yoldemir T, Kalkan U.Surgical challenges in the treatment of perimenopausal and postmenopausal endometriosis[J]. Climacteric, 2018,21(4):385-390. [13] Blümel JE, Arteaga E.Does menopause hormone therapy reduce the risk of chronic diseases[J]? Rev Med Chil, 2018,146(10):1170-1174. [14] Gao L, Wu X, Liu X, et al.Awareness of hormone replacement therapy in medical care personnel in Jiaxing, China: a questionnaire survey[J]. Gynecol Endocrinol, 2018,34(4):332-335. [15] Lund JM, Hladik F, Prlic M.Advances and challenges in studying the tissue-resident T cell compartment in the human female reproductive tract[J]. Immunol Rev, 2023,316(1):52-62. [16] Chen SM, Su J, Jin XH, et al.Effect of superfine powder and aqueous extract of Polygonati Rhizoma on rats with natural perimenopausal syndrome[J]. Zhongguo Zhong Yao Za Zhi, 2023,48(4):1054-1065. [17] Comeau KD, Shokoples BG, Schiffrin EL.Sex differences in the immune system in relation to hypertension and vascular disease[J]. Can J Cardiol, 2022,38(12):1828-1843. [18] Jiang L, Fei H, Yang A, et al.Estrogen inhibits the growth of colon cancer in mice through reversing extracellular vesicle-mediated immunosuppressive tumor microenvironment[J]. Cancer Lett, 2021,520:332-343. [19] Aurora R, Veis D.Does aging activate T-cells to reduce bone mass and quality[J]? Curr Osteoporos Rep, 2022,20(5):326-333. [20] Liu Xiaoli, Wang Kefang.Changes of serum Th1/Th2 type cytokine levels in patients with perimenopausal depression and its significance[J]. Modern Immunology,2022,42(06):505-510. [21] Yan S, Man Y, Lu J, et al.The "double-edged" role of progesterone in periodontitis among perimenopausal women undergoing or not undergoing scaling and root planning[J]. Front Endocrinol (Lausanne), 2023,14:1224763. [22] Bhadricha H, Patel V, Singh AK, et al.Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women[J]. Sci Rep, 2021,11(1):16155. [23] Abdi F, Mobedi H, Mosaffa N, et al.Effects of hormone replacement therapy on immunological factors in the postmenopausal period[J]. Climacteric, 2016,19(3):234-239. [24] Orsatti CL, Orsatti FL, Bezerra TG, et al.Interleukin-15 are associated with insulin resistance in postmenopausal women with metabolic syndrome[J]. Gynecol Endocrinol, 2022,38(9):765-770. [25] Shao MJ, Zhu YJ, Qiu YE, et al.Changes in the level of immunoglobulins and CD4/CD8 ratio in young and aged mice with estradiol deficiency[J]. Immunol Invest, 2017,46(3):305-313. [26] Chang SL, Durocher F, Diorio C.Sleep quality traits correlate with inflammatory markers in the breast tissue of women[J]. Cytokine, 2022,160:156028. [27] Gomez SE, Parizo J, Ermakov S, et al.Evaluation of the association between circulating IL-1β and other inflammatory cytokines and incident atrial fibrillation in a cohort of postmenopausal women[J]. Am Heart J, 2023,258:157-167. [28] Haley JS, Hibler EA, Zhou S, et al.Dose-dependent effect of aerobic exercise on inflammatory biomarkers in a randomized controlled trial of women at high risk of breast cancer[J]. Cancer, 2020,126(2):329-336. [29] Wu Liping, Duan Xiaopeng, Ma Yuliang, et al.Polycystic ovary image segmentation method based on improved U-Net network[J]. Chinese Journal of Biomedical Engineering,2022,41(6):663-671.
